Incidence of ROP in premature infants receiving and not receiving vitamin D
Design
Clinical trial with control group, parallel groups, Triple blind , randomized with a sample size of 35 people in any groups from March 2021 to March 2022
Settings and conduct
The design will be a Triple blind clinical trial under the NICU of Ghaem hospital of Mashhad University of Medical Sciences . Infants are randomly divided into two groups. Premature infants less than 34 weeks of gestation received vitamin D who received 10,000 units of vitamin D injections at birth were compared with infants which not use vitamin D, in terms of Retinopathy of prematurity(ROP). Diagnosis of ROP will be determined by an eye examination by a retinologist. The baby's vitamin D level is measured before the vitamin D injection. A sample containing 1.5 cc of whole blood will be taken from the umbilical cord for measure of vitamin D. The prepared samples will be centrifuged at -20 ° C and send for laboratory evaluation. Vitamin D level will be measured by Elisa Reader RT2100c Made in Germany and Elisa Washing Machine .
Participants/Inclusion and exclusion criteria
Inclusion criteria: Premature infants less than 34 weeks of gestation admitted to the neonatal intensive care unit
Conditions of absence: Obvious congenital anomaly, congenital infection, death in the delivery room, substance abuse by the mother
Intervention groups
Intervention groups: Premature infants less than 34 weeks of gestation admitted to the neonatal intensive care unit who receive 10,000 units of vitamin D, made by Caspian factory.
Control group: Infants less than 34 weeks gestational age admitted to neonatal intensive care unit who do not receive vitamin D at birth.
Main outcome variables
Presence or absence of Retinopathy of prematurity
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20110807007244N9
Registration date:2022-07-17, 1401/04/26
Registration timing:registered_while_recruiting
Last update:2022-07-17, 1401/04/26
Update count:0
Registration date
2022-07-17, 1401/04/26
Registrant information
Name
Hassan Boskabadi
Name of organization / entity
Mashhad University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 915 515 3987
Email address
boskabadih@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-06-22, 1401/04/01
Expected recruitment end date
2023-01-21, 1401/11/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of vitamin D injection at birth on the incidence of retinopathy of prematurity
Public title
The effect of vitamin D injection at birth on the incidence of retinal disorder of prematur infant
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Premature infants less than 34 weeks of gestational age admitted to the NICU
Exclusion criteria:
Overt congenital anomaly
Death in delivery room
Infants of drug-using mothers
Mothers of Asthma
Age
No age limit
Gender
Both
Phase
3
Groups that have been masked
Participant
Care provider
Investigator
Outcome assessor
Data analyser
Data and Safety Monitoring Board
Sample size
Target sample size:
35
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, block randomization will be used as a reliable randomization method that leads to a balanced allocation of individuals in treatment groups at the end of each block. For this purpose, using Random Allocation Software, a block randomization list with different sizes 4 or 6 is prepared, then according to the order of the contents of the blocks, which includes the group’s name and unique identification code, each patient is assigned to one of the groups
Blinding (investigator's opinion)
Triple blinded
Blinding description
By admitted of newborn, the nurs accidentally opens one of the blocks and, without knowing the grouping, presents one of the numbers to a researcher who is aware of the type of group. The researcher injects 10000 IU from ampoule of vitamin D into the newborn of the intervention group. The infant will be followed up by the principal investigator who is unaware of the type of group, of the presence or absence of respiratory problem. Data entry in SPSS is done as groups A and B, and the data analyst is unaware from the intervention or control group.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Mashhad university of medical sciences
Street address
NICU, Ghaem Hospital,Ahmadabad ST,Mashhad,Iran
City
Mashhad
Province
Razavi Khorasan
Postal code
9138813944
Approval date
2021-09-07, 1400/06/16
Ethics committee reference number
IR.MUMS.MEDICAL.REC.1400.478
Health conditions studied
1
Description of health condition studied
Vitamin D and neonatal problems
ICD-10 code
E55.9
ICD-10 code description
Vitamin D deficiency, unspecified
Primary outcomes
1
Description
present or unrepresented Retinopathy of prematurity
Timepoint
4 week after births
Method of measurement
retinal exam
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: remature infants less than 34 weeks of gestational age admitted to the Neonatal intensive care unit They will be injected once 10,000 units of vitamin D.
Category
Prevention
2
Description
Control group: Premature infants less than 34 weeks of gestational age who have been admitted to the neonatal intensive care unit and have not received 10,000 units of vitamin D.
Category
N/A
Recruitment centers
1
Recruitment center
Name of recruitment center
Ghaem Hospital
Full name of responsible person
boskabadi Hassan
Street address
Neonatal Intensive Care Unit, Pediatrics Dep, Ghaem Hospital, ahmadabad St.
City
Mashhad
Province
Razavi Khorasan
Postal code
91766-99199
Phone
+98 51 3841 2069
Email
boskabadih@mums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Majid ghayour mobarhan
Street address
Vice Chancellor for Research and Technology , Mashhad University of Medical Sciences, Ghoreishi building, Daneshgah Street, Mashhad
City
Mashhad
Province
Razavi Khorasan
Postal code
9138813944
Phone
+98 51 3840 0001
Email
ghayourm@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mashhad University of Medical Sciences
Position
professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
NICU, Pediatrics Dep, Ghaem Hospital, ahmadabad St.
City
Mashhad
Province
Razavi Khorasan
Postal code
91766-99199
Phone
00988412069
Email
Boskabadih@mums.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Boskabadi Hassan
Position
Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
NICU, Pediatrics Dep, Ghaem Hospital, ahmadabad St.
City
Mashhad
Province
Razavi Khorasan
Postal code
91766-99199
Phone
00988412069
Email
boskabadih@mums.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Boskabadi Hassan
Position
Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
Neonatal intensive care unit, Pediatrics Dep, Ghaem Hospital, ahmadabad St.
City
Mashhad
Province
Razavi Khorasan
Postal code
91766-99199
Phone
+98 51 3841 2069
Email
boskabadih@mums.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD